3,302 Shares in Colgate-Palmolive (NYSE:CL) Purchased by one8zero8 LLC

one8zero8 LLC bought a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 3,302 shares of the company's stock, valued at approximately $300,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Commonwealth Financial Services LLC grew its holdings in shares of Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock worth $247,000 after acquiring an additional 118 shares during the period. D Orazio & Associates Inc. grew its holdings in shares of Colgate-Palmolive by 4.2% during the 4th quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company's stock worth $271,000 after acquiring an additional 120 shares during the period. Lantz Financial LLC grew its stake in shares of Colgate-Palmolive by 0.6% in the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock worth $1,831,000 after buying an additional 122 shares during the last quarter. Horizon Kinetics Asset Management LLC grew its stake in shares of Colgate-Palmolive by 4.2% in the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company's stock worth $322,000 after buying an additional 124 shares during the last quarter. Finally, Pine Haven Investment Counsel Inc grew its stake in shares of Colgate-Palmolive by 1.0% in the 4th quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company's stock worth $1,182,000 after buying an additional 130 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several analysts recently weighed in on CL shares. Raymond James restated an "outperform" rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research note on Monday, February 3rd. UBS Group lowered their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $101.72.

Colgate-Palmolive Stock Performance

NYSE CL traded down $0.15 on Thursday, hitting $90.29. 5,570,261 shares of the company traded hands, compared to its average volume of 4,200,518. The company has a market capitalization of $73.28 billion, a price-to-earnings ratio of 25.65, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The business's 50 day moving average price is $89.19 and its 200-day moving average price is $94.41. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm earned $0.87 EPS. Equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.